E-Mail 'FDA Panel to Review Humira Colitis Data' To A Friend
Email a copy of 'FDA Panel to Review Humira Colitis Data' to a friend
Loading ...Gastroenterology training and education
Largest online gastroenterology, hepatology and endoscopy education and training resource with histology, x-ray images, videos, gastro calculators, and MCQs.
Loading ...FDA Panel to Review Humira Colitis Data
(MedPage Today) — Further studies may be needed to demonstrate clear benefits for the tumor necrosis factor (TNF) inhibitor adalimumab (Humira) in ulcerative colitis, FDA staff suggested.
FDA Panel to Review Humira Colitis Data
(MedPage Today) — Further studies may be needed to demonstrate clear benefits for the tumor necrosis factor (TNF) inhibitor adalimumab (Humira) in ulcerative colitis, FDA staff suggested.
FDA Panel to Review Humira Colitis Data
(MedPage Today) — Further studies may be needed to demonstrate clear benefits for the tumor necrosis factor (TNF) inhibitor adalimumab (Humira) in ulcerative colitis, FDA staff suggested.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information:
verify here.